Drug intelligence / Profile preview

quaternium-15

Development stage
Unknown
Lead developer
Dow
Modality
Small Molecules
Administration
Topical
01

Overview

Quaternium-15 is a synthetic quaternary ammonium salt used primarily as a surfactant and preservative in cosmetics, personal care products, and various industrial applications. It acts as an antimicrobial agent by slowly releasing formaldehyde, which provides biocidal properties. This mechanism also makes it a known human skin toxicant and allergen, capable of causing contact dermatitis especially in sensitive individuals. Quaternium-15 is approved for use in allergenic epicutaneous patch tests to aid the diagnosis of allergic contact dermatitis in persons aged six years or older. The compound exists as a mixture of cis and trans isomers; the cis form (Dowicil 200) is mainly used in cosmetics at concentrations up to 0.2% (EU limit), while mixed forms are found in industrial products such as paints, adhesives, metalworking fluids, and cleaning agents[3][5][6][7].

Brand names
Dowicil 200Dowicil200Dowicil-200Dowicil 75Dowicil75Dowicil-75Dowicil 100Dowicil100Dowicil-100
Other names
quaternium-15quaternium15quaternium 15hexamethylenetetramine chloroallyl chloride

Beyond the preview

Go deeper on quaternium-15.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on quaternium-15.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call